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Summary Numerous studies have indicated that the plasma membrane plays an important role in the
development of resistance to anthracycline and vinca alkaloid drugs (pleiotropic resistance). We have
previously shown that pleiotropically resistant Ehrlich ascites tumour cells, which are of epithelial origin, have
a significantly increased plasma membrane traffic (endo/exocytosis) to the endosomal compartment compared
to sensitive cells. The present study, using the same ultrastructural morphometric technique, has demonstrated
a similar significant difference in plasma membrane traffic between daunorubicin resistant and sensitive P388
cell lines (which are of lymphoid origin). Furthermore, we have shown that this difference between the P388
sublines is accompanied by an -4 fold increase in the plasma membrane area participating in recycling
together with an increased endosomal volume, number and membrane area in resistant cells. Plasma
membrane traffic in resistant cells was significantly inhibited by the calcium channel blocker verapamil, a well
known modulator of anthracycline resistance, but unaffected by daunorubicin itself. The confirmation of this
phenotype in an additional pleiotropically resistant cell type with a different histogenesis further supports a
hypothesis of.endosomal drug trapping and vesicular extrusion as a possible resistance mechanism.
Increasing attention has been paid to the possible role(s) of
the plasma membrane in the development of pleiotropic drug
resistance. We have recently observed a significant increase
in plasma membrane traffic in four Ehrlich ascites tumour
(EHR) lines resistant to daunorubicin (DNR), doxorubicin
(DOX), vincristine (VCR) and vinblastine (VBL) respec-
tively, compared to the sensitive parent cell line (Sehested
et al., 1987), and concluded that the finding could signify
either (1) a resistance linked phenotype without significance
for resistance per se; (2) an increase in plasma membrane
repair and/or receptor recycling; or (3) drug trapping in
the endosomal-lysosomal complex, by electrostatic forces
and/or binding to an unspecified receptor(s), and subsequent
exocytosis to the extracellular medium. In order to confirm
these results, we wished to examine plasma membrane traffic
in relation to pleiotropic resistance in another cell type.
Further, we wished to examine whether DNR per se or
verapamil, a well known modulator of anthracycline resis-
tance, had any effect on plasma membrane recycling.
P388 cells sensitive and resistant to DNR were chosen for
the following reasons: EHR and P388 leukaemic cells have a
different histogenesis as EHR are derived from a murine
mammary epithelial tumour (Ehrlich & Apolant, 1905) while
P338 cells originate from a murine lymphocytic tumour
(Dawe & Potter, 1957). Furthermore, it has recently been
reported that cells from both human, murine and monkey
lymphoid cell lines have a low pinocytotic capacity
compared with epithelial HeLa cells (Goldmacher et al.,
1986). In addition, P388 cells have been extensively studied
in relation to pleiotropic resistance, and the ability of drug
resistant P388 cells to extrude anthracycline drugs by an
energy dependent mechanism appears to be similar to that of
resistant EHR (Inaba et al., 1979).
Finally, in addition to studying the magnitude of plasma
membrane traffic as previously described in EHR, we also
wished to examine the endosomal compartment as defined
by number, volume and membrane area of endosomes in
sensitive and DNR resistant P388 cells to see whether these
cell lines differed from each other with respect to the
morphology of this organelle as well as to its ability to
participate in plasma membrane recycling.
Materials and methods
Tumour cells
Wild-type P388 murine leukaemia cells (P388/S) were
obtained from F.M. Shabel, Southern Research Institute,
Birmingham, Alabama, and maintained as ascitic tumours in
first-generation hybrids of female Swiss mice and male
inbred DBA/2 mice by weekly transplantation of 107 cells
per mouse. A DNR resistant P388 subline (P388/DNR+)
was developed in vivo by treatment with increasing doses of
DNR during weekly passages of the tumour. The resistant
subline was maintained by i.p. treatment with a dose of
DNR corresponding to LD10 as previously described (Dan0,
1971). That P388/DNR+ are not only resistant to DNR,
but also show cross resistance (pleiotropic resistance) to a
LDlO dose of VCR (as determined by Dan0, 1972), is
demonstrated in Table I.
DNR was omitted in the last passage before experiments.
Chemicals
Daunorubicin as hydrochloride was obtained from
Farmitalia, Milan, Italy and verapamil from Meda A/S,
Copenhagen, Denmark. Both chemicals were of analytical
grade.
Experimental procedure
This was as previously described (Sehested et al., 1987)
except for labelling periods. Briefly: cells were first washed
four times in ice-cold Ringer's solution, suspended in
phosphate buffered saline to a cell concentration of
2 x 106 ml- I and labelled with cationized ferritin (CF) (Miles
Laboratories Inc., Elkhart, Indiana) at a final concentration
of 0.1mgml- for 15min at 4°C. After labelling, glucose
was added to a final concentration of 10mm, and, when
appropriate, either DNR (5/iM) or verapamil (25/IM). There-
after, test tubes containing 2ml CF labelled cell suspension
were transferred to 37°C for either 15 or 45min before
fixation with 2ml 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer for I h at 24°C. Four 1 mm3 pellets were
obtained from each of 2 test tubes from each of the 3
experimental periods (15min 4°C, 15 and 45min at 37°C) by
centrifugation in 0.3 ml tubes. After postfixation in 2%
OsO4, dehydration and embedding in Epon, 2 of the 4
pellets were randomly chosen for ultrathin sectioning and
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Table 1 Effect of DNR and VCR on P388/S and P388/DNR+
Median
Tumour Drug Dosea No. mice survivalb Range ILSC
Control 21 13 (11-18)
P388/S DNR 1.5 15 35 (17-55) 169%
VCR 0.5 15 21 (17-32) 62%
Control 15 12 (10-22)
P388/DNR+ DNR 1.6 11 13 (11-16) 8%
VCR 0.5 11 13 (12-15) 8%
aDose in mgkg i.p. per day for 4 consecutive days. Dosage for
both DNR and VCR correspond to LD1O as previously determined
by Dan0 (1971; 1972); bMedian survival in days after start of
treatment. clncreased median life span compared to controls.
Table II Surface area ratio of CF labelled plasma membrane area
to total plasma membrane area, SS(CFm,m)a
Cell type Median 95% CLb J4C
P388/S/4oCd 0.875 0.850-0.900 45
P388/S/15e 0.727k 0.690-0.765 59
P388/S/45f 0.736' 0.647-0.750 54
P388/DNR+/4oCd 0.865 0.844-0.875 38
P388/DNR+/15e 0.428k.m 0.306-0.455 46
P388/DNR+/15/DNR9 0.397 0.211-0.482 53
P388/DNR+/15/VERi 0.49m 0.346-0.563 50
P388/DNR+/45f 0.2861,n 0.235-0.318 49
P388/DNR+/45/DNRh 0.326 0.194-0.417 49
P388/DNR +/45/VERi 0.44n 0.353-0.474 45
aSurface area ratio of CF labelled plasma membrane to total
plasma membrane demonstrating a significantly greater decrease at
both 15 and 45min at 370C in P388/DNR+ compared to P388/S;
b95% confidence limits of the median; CNumber of whole cell
profiles; diSmin at 4°C; el5min at 37°C; f45min at 37°C; lSmin at
37°C with SUM DNR; h45min at 37°C with 5,pM DNR; 'I5min at
37C with 25pM verapamil; 45min at 37C with 25 pM verapamil; kp<0.oO1; 'P<0.001; mP<0.05; np<0.001 (Mann-Whitney rank
sum test).
coded. Experiments with P388/S and P388/DNR+ cells were
carried out simultaneously and repeated after 2 weeks. Thus
the total material examined by electron microscopy was 8
blocks (pellets) from each experimental period and cell type.
Morphometric procedure
Morphometric evaluation was carried out using a 5:1
coherent double lattice test system as previously described
(Sehested et al., 1987) with a distance between fine lines of
0.501 pm. The following absolute values (per mean cell) were
calculated: the median area of the total plasma membrane
surface, the median volume of intracellular CF, V(CFi,c)
(Table III), median endosomal volume, V(End,c) (Table IV),
median area of CF labelled intracellular membrane, S(CFi,c)
(Table V), the median endosomal membrane area, S(End,c)
(Table VI) and the median surface area ratio of the CF
labelled plasma membrane to the total plasma membrane
area, SS(CFm,m) (Table II). Mean cell volumes were
determined for each experimental period by measuring the
diameters of 300 cells at a magnification of x 1,000.
In addition, the median number of endosomes per mean
cell, N(End,c) =NV(End,c) x V,was calculated according to the
method of Weibel and Gomez (Weibel, 1979) from the
equation NV=(K/fl) xy/(NA3/pp) (Table VII), where NV is
the number of profiles per unit volume, NA the number of
profiles per unit area and PP the number of profile test
points divided by the total number of test points. K was
determined by the coefficient of variation in each test group.
The value of ,B was chosen as that of a sphere (1.38), which
is an approximation as endosomes are not truly spherical.
However this coefficient varies little for short-axed ellipsoids.
Finally, the size distributions of endosome profile diameters
were calculated from direct measurements of all endosomal
profiles (Figure 4). Endosomes are defined in this context as
any clear vesicular intracellular profile, regardless of size,
which contains CF and is without the typical dense
lysosomal matrix.
For statistical analysis the Mann-Whitney rank sum test
(two-tailed for unpaired observations) was used. A P value
of <0.05 was considered a statistically significant difference.
Results
The ultrastructural appearance of P388 cells reflects their
lymphoid histogenesis in that the cytoplasm has few
organelles and instead largely contains free ribosomes
(Figures 1-3). Unlabelled P388/DNR + cells appeared to
Figure 1 P388/S cell incubated with CF for 45min at 37°C.
Although the surface labelling is distinct, no endocytosed CF is
seen in this cell profile. The cytoplasm contains mitochondria, a
few cisterns of endoplasmic reticulum, and numerous free
ribosomes. x 28,000. Bar=0.5pm.
Figure 2 P388/DNR+ cell incubated with CF for 45min at
37°C. Internalized CF is present in some large peripheral
endosomes (En). x 28,000. Bar=0.5,um.
Figure 3 P388/DNR+ cell incubated with CF for 45min at
37°C. In this micrograph CF is seen in structures localized more
to the centre of the cell: a typical small endosome (En),
structures appearing as. multivesicular bodies (Mvb), and dense
bodies (Db) - presumably representing lysosomes. A small
unlabelled Golgi complex (Go) is also shown. x 37,000.
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have more endocytotic structures (vacuoles and multi-
vesicular bodies) than P388/S cells. As also observed in EHR
cells (Sehested et al., 1987), P388 cells showed a decrease in
cell volume after transfer from 4°C to 37°C with a cor-
responding rise in the surface to volume ratio of plasma
membrane to cell so that the cell surface area was constant
(data not shown).
All the morphometric variables used to examine both
plasma membrane traffic as well as the endosomal
compartment demonstrated a highly significant (P<0.001)
difference between P388/S and P388/DNR+ cells (as
exemplified in Figures 1-3). In fact, the endosomal
compartment in P388/S cells was so small as to be below the
'detection level' of the morphometric assay used as regards
volume and numerical density determinations, as shown by
the median zero values in Tables III, IV and VII. The
medians of the variable distributions are therefore
supplemented with the distribution range in these tables to
show that the endosomal compartment, though small, was
present in P388/S cells.
The three variables designating endocytosis, viz surface
area ratio of CF labelled plasma membrane to total plasma
membrane area (Table II), volume of intracellular CF per
cell (Table III) and surface area of intracellular CF labelled
membrane (Table V) all show a significantly greater rate of
endocytosis in P388/DNR+ compared to P388/S.
Furthermore, in all three variables, P388/S cells fail to
demonstrate further endocytosis after 15min while
P388/DNR+ cells continue to do so, though at a lower rate
than during the first 15min.
On the other hand, the three variables designating the
endosomal compartment of the cells, viz endosomal volume
(Table IV), membrane area of endosomes (Table VI) and
endosomal number (Table VII) show no significant
difference between 15 and 45min in either cell line. However,
P388/DNR+ cells have a significantly greater endosomal
compartment then P388/S cells as evidenced by all three
variables. This increase in endosomal compartment in
P388/DNR+ cells is not only due to a larger number of
endosomes, but also to an increase in the individual
Table III Volume of intracellular CF per cell, V(CFi,c) (Um3)a
Cell type Median 95% CLb Range
P388/S/4-C 0 0-0 0- 0
P388/S/15 0c 0-0 0- 4.10
P388/S/45 od 0-0 0-11.12
P388/DNR+/40C 0 0-0 0- 2.25
P388/DNR+/15 1.45cCe 0-3.36 0-20.16
P388/DNR +/45 4.56d.e 3.6-6.8 0-27.2
aVolume of intracellular CF per mean cell in P388/S and
P388/DNR+ demonstrating a significantly greater increase in
P388/DNR+ compared to P388/S at both 15 and 45min at 37°C;
b95%confidence limits of the median; CP<0.001; dp<0.001;
ep<0.005 (Mann-Whitney rank sum test). For explanation of cell
types see Table II.
Table IV Endosomal volume per cell, V(End,c) (Um3)a
Cell type Median 95% CLb Range
P388/S/4-C 0 0-0 0- 1.88
P388/S/15 0c 0-0 0-15.01
P388/S/45 od 0-0 0-11.12
P388/DNR+/40C 0 0-0 0- 2.25
P388/DNR+/15 4,71c,e 1.95-7.66 0-75.26
P388/DNR+/45 7.75d,e 4.56-9.59 0-36.2
aEndosomal volume per mean cell showing a significant difference
between P388/S and P388/DNR+ at both 15 and 45min at 37°C.
Note lack of significant difference between P388/DNR+ at 15 and
45min at 37°C. "95% confidence limits of the median; CP<0.001; dp<0.001; 'NS. For explanation ofcell types see Table II.
Table V Surface area of intracellular labelled
membrane, S(CFi,c) (pm2)a
Cell type Median 95% CLb
P388/S/4°C 0 0-0
P388/S/15 8.4c e 0-10.7
P388/S/45 11.7d e 0-17.8
P388/DNR+/4° 0 0-0
P388/DNR+/15 43.1c f 24.2-53.1
P388/DNR+/45 72.8d.f 52.4-98.6
aSurface area of intracellular CF labelled membrane
per mean cell demonstrating a significantly greater
amount in P388/DNR+ cells at both 15 and 45min at
37°C. Note lack of significant rise in P388/S between
15 and 45min at 37°C while this is evident in
P388/DNR+. b95% confidence limits of the median;
CP< 00.1; dp<0.001; eNS; fP<0.01 (Mann-Whitney
rank sum test). For explanation of cell types see Table
II.
Table VI Endosomal membrane area per cell,
S(End,c) (pm2)a
Cell type Median 95% CLb
P388/S/4-C 0 0-0




P388/DNR+/45 95.5d f 69.4-125.1
aEndosomal membrane area per mean cell showing a
significantly larger area in P388/DNR+ compared to
P388/S. Note lack of significant difference between 15
and 45min at 37°C in both cell lines; "95% confidence
limits of the median; cp<0.001; dp<0.001; 'NS; fNS
(Mann-Whitney rank sum test). For explanation of
cell types see Table II.
Table VII Number of endosomes per cell, N(End,c)a
Cell type Median 95% CLb Range
P388/S/40C 0 0-0 0-12
P388/S/15 0c e 0-0 0-772
P388/S/45 ode 0-0 0-537
P388/DNR+/40C 0 0-0 0-42
P388/DNR+/15 139C.f 81-237 0-1953
P388/DNR+/45 205df 141-269 0-2054
aNumber of endosomes per mean cell demonstrating a significant
difference between P388/S and P388/DNR+. Note lack of
significant difference between 15 and 45min at 370C in both cell
lines; b95% confidence limits of the median. cp<0.001; dp<0.001;
eNS; fNS (Mann-Whitney rank sum test). For explanation of cell
types see Table II.
endosomal volume as reflected by the distributions of the
endosome profile diameters shown in Figure 4.
As shown in Table II, incubation with DNR was without
effect on endocytosis in P388/DNR+, while verapamil had
an inhibitory influence which was significant at both 15min
(P<0.05) as well as at 45min (P<0.001).
Discussion
The present study has focused on 3 aspects of the pleio-
tropically resistant cell viz (1) its capacity for recycling
plasma membrane; (2) its endosomal compartment as
defined by endosomal number, volume and membrane area;
and (3) the influence on plasma membrane traffic by both
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Figure 4 Size distributions of endosome profiles in P388/S and P388/DNR+ at 15 and 45min at 37°C. Note marked difference
between the 2 cell lines but similar distributions at 15 and 45min in both cell lines. Abscissa=endosomal profile diameters in nm.
as by verapamil, a well known anthracycline resistance
modulator in P388 cells (Kessel & Wilberding, 1985; Tsuruo
et al., 1982).
P388/DNR+ cells endocytosed significantly more CF than
P388/S cells, which is in agreement with the results of Basrur
et al. (1985) who studied the uptake of fluoresceinated lectins
in P388/S and P388 cells resistant to DOX. In contrast to
P388/DNR+ cells, P388/S cells showed no increase in
endocytosis of CF between 15 and 45min, indicating that the
amount of plasma membrane available for recycling is
significantly less in sensitive cells. Thus, after 45min 14% of
the CF coated plasma membrane had been endocytosed in
P388/S cells compared to 58% in P388/DNR+ cells (Table
II). The low endocytotic rate in P388/S cells agrees well with
the findings of Goldmacher et al. (1986) who described a low
capacity ofpinocytosis in 4 lymphoblastic cell lines.
As demonstrated in Tables IV, VI and VII and in
Figure 4, the endosomal compartment ofP388/DNR+ cells is
significantly increased compared to P388/S cells. This is in
agreement with recent reports stating that CEM human
leukaemia cells resistant to VBL, by light microscopy, have a
larger number of lipid negative cytoplasmic vacuoles
compared to sensitive cells (Zamora & Beck, 1986), and that
DOX resistant human intestinal 1-407 cells, by electron
microscopy, contain a larger number of transport vesicles
near the plasma membrane than do sensitive 1-407 cells (Geri
et al., 1986). Of particular interest are the results showing a
constant endosomal content in P388/DNR+ cells between
15 and 45min despite the above mentioned evidence of
increased endocytosis during this period. These findings,
together with the measurements showing a constant cell
surface area during the experiments (data not shown)
indicate that (1) the plasma membrane is recycling as would
be expected from other studies (Mellman, 1984); (2) that CF,
in itself, hardly significantly stimulates endocytosis (as
evidenced by the very modest rate of endocytosis in P388/S);
and (3) that the increased capacity to recycle plasma
membrane in P388/DNR+ is not solely due to an increase
in speed of vesicular traffic (in which case the endosomal
content would be equal in the two cell lines).
One of the features of the pleiotropic resistance phenotype
is the ability of resistant cells to extrude the drug in question
in an energy dependent manner (Skovsgaard & Nissen,
1982). However, the significance and nature of this feature
have yet to be determined. We have previously reported that
membrane traffic between the plasma membrane and the
endosomal system was significantly increased in 4 pleiotropic
resistant EHR cell lines compared to the sensitive EHR line
(Sehested et al., 1987), and hypothesized that this
phenomenon could offer an explanation of the increased
active drug extrusion in resistant cells via drug trapping in
the endosomal system and exocytosis therefrom to the extra-
cellular medium. A possible method of drug trapping in the
acid endosomal compartment could be by protonation of the
respective alkaline anthracycline and vinca alkaloid drugs. In
support of a pH-dependent drug trapping mechanism are
reports on the circumvention of pleiotropic resistance by
such dissipators of the endosomal proton gradient as
chloroquine and methylamine (Klohs & Steinkampf, 1986;
Shiraishi et al., 1986; Zamora & Beck, 1986), as well as the
inhibition of drug extrusion in resistant cells by chloroquine
(Shiraishi et al., 1986). Furthermore, DOX is rapidly trapped
in unilamellar vesicles in response to a transmembrane pH
gradient with an acidic interior, with a trapping efficiency up
to 98% and an interior drug concentration as high as
100mM (Mayer et al., 1986). However, Cornwell et al. (1986)
found that plasma membrane and endocytotic vesicles
prepared from pleiotropically resistant KB cells bound up to
-mm
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8 fold more VBL than did vesicles from parental or revertant
KB cells in a trypsin dependent, NH4C1 independent
fashion, signifying the additional possibility of drug trapping
by a protein receptor. A likely candidate for such a protein
would be the P-glycoprotein described by Juliano & Ling
(1976), which is commonly overexpressed in highly resistant
in vitro cell lines, and has been detected both in the above
mentioned resistant KB line (Shen et al., 1986) as well as in
a DOX resistant P388 in vitro cell line (Kessel & Corbett,
1985). Whether P-glycoprotein is also overexpressed in our in
vivo resistant cell lines, which are of relatively low resistance
compared to in vitro lines, is currently under investigation.
Studies by Kessel & Wilberding (1985) and Tsuruo et al.
(1982) have demonstrated that calcium channel blockers such
as verapamil, as well as calmodulin inhibitors, are able to
reverse pleiotropic resistance, and inhibit active DNR efflux
in DOX resistant P388 cells by an as yet undetermined
mechanism. We have shown that verapamil, in a dose that
nearly completely inhibits active DNR efflux in both DOX
resistant P388 cells (Kessel & Wilberding, 1985), as well as in
DNR resistant EHR cells (Friche et al.), also significantly
inhibits plasma membrane traffic in P388/DNR+.
Calmodulin inhibitors have also been described to decrease
vesicular traffic (Kuratomi et al., 1986; Salisbury et al.,
1980). Further, Tsuruo & Iida (1986) found that
cytochalasin, another drug which is presumed to disrupt
vesicular traffic, inhibited the outward transport of DNR
from DOX resistant P388 cells.
Thus, the present study supports a role for increased
plasma membrane flow and endosomal content in pleiotropic
resistance.
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